IT-29 IMMUNE CHECKPOINT BLOCKADE FOR GLIOBLASTOMA: PRECLINICAL ACTIVITY OF SINGLE AGENT AND COMBINATORIAL THERAPY

BACKGROUND: Outcome for glioblastoma (GBM) remains dismal and innovative treatment strategies are desperately needed. Growing data support the contribution of local and systemic immune checkpoint molecules mediating immunosuppression by GBM tumors. METHODS: Luciferized GL261 cells (GL261-Luc) were s...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Reardon, David, Gokhale, Prafulla, Ligon, Keith, Liao, Xiaoyun, Rodig, Scott, Zhou, Jun, Qin, Lei, Hodi, Stephen, Jones, Kristen, Sauer, Amy, Kohl, Nancy, Dranoff, Glenn, Freeman, Gordon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2014
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218246/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.27
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia